DocGo Inc., a New York-based provider of technology-enabled mobile health services, reported the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. The deal was announced on February 10, 2025.
Health specializes in serving patients who are homebound or face transportation challenges, and its clinicians perform thousands of lab collections every year. PTI Health’s phlebotomists perform in-home blood draws and other collections, enabling seamless diagnostics and care gap closure in collaboration with patients’ healthcare providers. PTI also supports mobile clinical trials.
DocGo is a leading provider of last-mile mobile care services and integrated medical mobility solutions. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. DocGo merged with special purpose acquisition company Motion Acquisition Corp. in November 2021.
The acquisition of PTI Health expands DocGo’s healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate blood collection and additional at-home testing services for patients. Initially, DocGo plans to expand PTI Health’s operations into New York City. As part of the acquisition, PTI Health President Wayne Meadows will join DocGo as a General Manager. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this transaction marks the 15th Laboratories, MRI and Dialysis acquisition of 2025, and the sixth in the diagnostic specialty. There were 63 diagnostic deals announced in both 2024 and 2023.
